AMT-676 in Patients With Advanced Solid Tumors
NCT06400485
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
AMT-676
Sponsor
Multitude Therapeutics Inc.